In recent years, collaborations often between mathematical and computational biologists and scientists in the World Health Organization (WHO) global influenza surveillance network, have resulted in a number of mathematical and computational advances including: increasing the resolution at which antigenic surveillance data can be analyzed, providing methods for genetic analysis and prediction, and an increased understanding of the determinants of repeated influenza vaccination. These advances increase the information extracted from influenza surveillance and increase the quantitative data available for the vaccine strain selection process. This mathematical and computational work is possible because of the wealth of information collected over many years by the WHO global influenza surveillance network, and further advances will be greatly facilitated by implementation of the proposed strengthening of virological and epidemiological surveillance in the WHO global agenda on influenza surveillance and control. © 2003 Elsevier Science Ltd. All rights reserved. • quantitative data on influenza surveillance; and • insights into the process of vaccine strain selection.
Introduction
New high-throughput methods in biology are producing data at an unprecedented rate. In many areas of biology, traditionally experimental scientists are collaborating with computational scientists from many disciplines to create new methods in bioinformatics and computational biology to analyze these data. New patterns are being discovered which would not be detectable without systematic and automated approaches because of the volume and often noisy nature of the data. Although many of these methods are in their infancy, there is no doubt that major advances in our basic understanding of biology, and practical applications in medicine and public health will ensue.
The influenza surveillance and vaccine strain selection processes are in a good position to take advantage of these new methods. The long-standing WHO global influenza surveillance network has accumulated a great deal of institutional knowledge and has collected an extensive dataset of the antigenic and genetic evolution and epidemiology of influenza [1] , a subset of this dataset exists in centralized databases [2] [3] [4] [5] , and the WHO global agenda on influenza surveillance and control proposes further critical strengthening virological and epidemiological surveillance [6, 7] .
Application and development of these new methods to influenza surveillance and vaccine strain selection is already ongoing. In recent years, collaborations often between scientists in the WHO global influenza surveillance program and mathematical, evolutionary, and computational biologists have resulted in a number of mathematical and computational advances in understanding the antigenic and genetic evolution of influenza and an increased understanding of the determinants of the efficacy of repeated influenza vaccination. Here we give a brief overview of the data used in the vaccine strain selection process, and then review how mathematical and computational methods are being applied to these data, and what might be possible in the future.
The necessity to update the influenza vaccine, and the data used to do so
Human influenza is a complex pathogen, mostly because of its capacity to vary its surface proteins to escape immune surveillance. There are two main patterns of change [8] . The first, antigenic shift, is the result of a new influenza A subtype entering the human population, either directly or indirectly from birds. There is generally little pre-existing immunity to the new subtype and antigenic shifts can cause worldwide influenza pandemics. The second, antigenic drift, is the result of changes in existing human influenza viruses, to escape immune surveillance. If the influenza vaccine were not updated to track the antigenic changes in the virus, the vaccine would cease to be effective; hence, twice-yearly vaccine strain selection meetings recommend any necessary updates to the influenza strains used in the vaccine.
The vaccine strain selection decision is primarily based on three criteria: (1) antigenic, is there a significant antigenic difference between emerging strains and the existing vaccine strain; (2) genetic, is there supporting evidence of change in the genetic data; and (3) epidemic, are the emerging strains likely to cause widespread epidemics in the coming season. The data to assess these criteria are generated by the WHO global influenza surveillance network of sentinel physicians, National Influenza Centers, and collaborating centers for reference and research. There is mathematical and computational work ongoing to increase the information available to the vaccine strain selection process for all three of these criteria.
Increasing the resolution and visualization of antigenic data
Antigenic changes in the influenza virus are measured using the hemagglutination inhibition (HI) assay. The HI assay has been a tool for vaccine strain selection and research for many years [9, 10] . The assay works well for distinguishing major drift variants, but finer-grain differences are difficult to judge reliably. New mathematical methods have been applied to the analysis of HI data which increase the resolution at which antigenic differences can be reliably measured, and also produce a visualization of the antigenic relationships among many strains [11] (Smith et al., manuscript in preparation) (see [12] [13] [14] for related work). These antigenic maps reveal details of both the short-and long-term patterns of antigenic evolution, increase the granularity at which antigenic surveillance data can be examined, and thus increase the information available to the vaccine strain selection process. Antigenic maps can ameliorate some of the difficulties in comparing HI data from different laboratories and thus open the way for curation of antigenic data in a centralized database. Also, the finer-grain quantification of antigenic data opens up basic research in, among other areas, antigenic evolution, and the relationship between genetic mutations and their antigenic effects.
Predicting genetic evolution from the genetic data
Genetic data is more precise than antigenic data and there is a long history of detailed quantitative work on the genetic evolution of influenza. Most of this work is focuses on the hemagglutinin gene because of its primary role in antigenic drift [15, 16] . Advances in the methods of evolutionary biology [17] and careful analyses of the intricacies of influenza data [18] , have resulted in the identification of 18 positively selected codons in the hemagglutinin gene [19] . In a retrospective analysis, these codons predicted, from among circulating strains, the genetic variants that were the progenitors of future lineages in 9 of 11 seasons [20] . Monitoring changes in these 18 codons might help to predict the future evolution of the virus.
Mathematical techniques have been used to identify clusters in genetic data. In a retrospective analysis, a strain chosen from the most dominant genetic cluster of one season matched the WHO vaccine choice for the following season in 9 of 16 seasons [21] (see [40] for commentary). These clusters also enabled new analyses and quantification of the antigenic sites on the hemagglutin gene. Genetic clusters can also be visualized in genetic maps constructed using similar techniques to those used to construct antigenic maps. High-throughput sequencing of many strains will further enable genetic analyses, by providing not only more data, but also by reducing the sampling bias in the current data.
Modeling influenza epidemiology
The third consideration in vaccine strain selection is whether newly emerging strains are likely to cause widespread epidemics in the coming season. Current epidemiological models are not yet at the point of being able to help answer this question. However, influenza epidemics in closed settings, such as single outbreaks in nursing homes, can be accurately modeled [22] using modifications of classic susceptible-infectious-recovered techniques [23] , and these models might provide guidance for the most effective use of antivirals in a pandemic situation [24] . However, to model interpandemic epidemiological patterns, models may will have to take into account antigenic drift of the virus, immunity after infection or vaccination with multiple related but different strains [25] , vaccine coverage [41] [42] [43] , seasonal variation [44] , and spatio-temporal effects [45] (see [26] for a review). Adding antigenic dirft and cross-immunity into classical models greatly complicates the mathematics and although advances have been made, much work remains [27] [28] [29] . Advances in incorporating spatio-temporal information into epidemiological models has been successful in models of other pathogens including measles, whooping cough, and foot and mouth disease [30] [31] [32] [33] [34] , and some progress has been made for influenza though much work remains [35, [46] [47] [48] .
A major reason for successes in epidemiological modeling of other pathogens is the availability of detailed spatio-temporal data. For influenza one needs not only spatio-temporal data but also virological data; thus, the proposed improvements coverage and harmonization of epidemiological surveillance, the linking of epidemiological and virological data, and the entering of these data in the influenza databases as proposed by the global agenda on influenza surveillance and control, will be of significant benefit to future epidemiological modeling work.
Optimizing vaccine strain selection for increased efficacy in repeat vaccinees
Vaccine strain selection is currently optimized to give a good match between the vaccine strains and the strains expected to circulate in the coming influenza season. This is the optimal strategy for first-time vaccines, but there is some evidence to suggest that modifications to this strategy might improve efficacy in repeat vaccinees. The efficacy of repeated vaccination has been difficult to determine definitively as different studies have come to different conclusions [36, 37] . A meta-analysis of repeated vaccination studies showed that, on average, repeat vaccinees are as well protected as first-time vaccinees, but that vaccine efficacy in repeat vaccinees is more variable than efficacy in first-time vaccinees [38] . The antigenic distance hypothesis has been proposed to explain this variability, and a corollary of the hypothesis is that there is a trade-off in vaccine strain selection: while selecting a vaccine strain close to the expected epidemic strains increases vaccine efficacy, a vaccine strain too close to previous vaccine strains will, in some circumstances, be less effective in repeat vaccinees than in first-time vaccinees [25] . This reduced efficacy is likely due to elimination of vaccine antigen by pre-existing cross-reactive antibodies raised by prior influenza vaccination or infection. Influenza vaccination guidelines recommend annual revaccination for at-risk individuals; thus, a case can be made for optimizing vaccine strain selection for repeat vaccinees. Mathematical modeling of vaccine strain selection strategies, that take into account the antigenic distance hypothesis, suggests strategies that have the potential to increase vaccine efficacy in repeat vaccinees [39] (Smith et al., manuscript in preparation). These strategies are based on modifications of the current strategy and all give higher efficacy when there is a good estimate of the next drift variants; thus, the potential to optimize the vaccine choice for repeat vaccinees is dependent on the current methodology and any improvements that can be made to it, such as those described above and those proposed by the global agenda, will also increase the potential of these alternate strategies.
Summary
The wealth of data collected by the WHO global influenza surveillance network, and the subset of it stored in the influenza sequence database and influenza epidemiological databases, have enabled recent mathematical and computational advances in our basic understanding of the genetic and antigenic evolution of influenza. Coupled with an increased understanding of the determinants of the efficacy of repeated vaccination, these new methods increase the quantitative information available to the influenza surveillance and vaccine strain selection processes. Further advances in mathematical and computational biology, and its application to influenza, will be greatly facilitated by implementation of the proposed strengthening of virological and epidemiological surveillance by the WHO global agenda on influenza surveillance and control.
